| Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma (NCT01635270) | Centre Leon Berard | 2012-09-12 |
| The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy (NCT02135679) | Abramson Cancer Center at Penn Medicine | 2012-09-01 |
| An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients (NCT01844791) | Oncozyme Pharma Inc. | 2012-09-01 |
| Lung Cancer Information Study (LCIS-R01) (NCT01924416) | University of Virginia | 2012-09-01 |
| Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer (NCT01700400) | Cancer Research and Biostatistics Clinical Trials Consortium | 2012-09-01 |
| Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment (NCT01707329) | Betta Pharmaceuticals Co., Ltd. | 2012-09-01 |
| Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (NCT01647867) | Centre Oscar Lambret | 2012-08-27 |
| Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer (NCT01666977) | Amgen | 2012-08-01 |
| A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC] (NCT01714037) | Debiopharm International SA | 2012-08-01 |
| Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma (NCT01574729) | Shenzhen SiBiono GeneTech Co.,Ltd | 2012-08-01 |
| Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention (NCT01687738) | University of North Carolina, Chapel Hill | 2012-08-01 |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) (NCT01511081) | M.D. Anderson Cancer Center | 2012-08-01 |
| Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer (NCT01688713) | Zhejiang Cancer Hospital | 2012-08-01 |
| A Study of LY3023414 in Participants With Advanced Cancer (NCT01655225) | Eli Lilly and Company | 2012-07-31 |
| Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project (NCT02459002) | M.D. Anderson Cancer Center | 2012-07-18 |
| First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients (NCT01646450) | Betta Pharmaceuticals Co., Ltd. | 2012-07-01 |
| MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases (NCT01640847) | Imunon | 2012-07-01 |
| Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease (NCT01784549) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2012-07-01 |
| A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin (NCT01641575) | Clovis Oncology, Inc. | 2012-07-01 |
| Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity (NCT01639508) | Memorial Sloan Kettering Cancer Center | 2012-07-01 |
| BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (NCT01660776) | Rennes University Hospital | 2012-06-07 |
| Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer (NCT01619241) | The Catholic University of Korea | 2012-06-01 |
| Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation (NCT01745484) | University of Aarhus | 2012-06-01 |
| Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology (NCT01596452) | National University Hospital, Singapore | 2012-06-01 |
| Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer (NCT01605916) | AstraZeneca | 2012-06-01 |
| Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer (NCT01625234) | Xcovery Holdings, Inc. | 2012-06-01 |
| Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates (NCT01630122) | Wake Forest University Health Sciences | 2012-06-01 |
| Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy (NCT01808677) | M.D. Anderson Cancer Center | 2012-06-01 |
| Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan) (NCT01597258) | Pfizer | 2012-05-29 |
| Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer (NCT02720614) | LIN QIANG | 2012-05-01 |
| EGF Ointment for Erlotinib Skin Lesion (NCT01593995) | Dong-A University Hospital | 2012-05-01 |
| Perioperative Rehabilitation in Operation for Lung Cancer (NCT01893580) | Rigshospitalet, Denmark | 2012-05-01 |
| Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (NCT01525199) | AstraZeneca | 2012-05-01 |
| Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer (NCT01545947) | Celgene | 2012-05-01 |
| ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer (NCT01580735) | Kyowa Kirin Co., Ltd. | 2012-05-01 |
| A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 (NCT02340208) | Helix BioPharma Corporation | 2012-05-01 |
| A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment (NCT01610336) | Novartis Pharmaceuticals | 2012-04-05 |
| A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) (NCT01562015) | Synta Pharmaceuticals Corp. | 2012-04-01 |
| First Line Gefitinib by FDG-PET Metabolic Response (NCT01510990) | Asan Medical Center | 2012-04-01 |
| A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer (NCT02364804) | Shiga University | 2012-04-01 |
| Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer (NCT01607554) | New Mexico Cancer Research Alliance | 2012-04-01 |
| Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer (NCT01617980) | German Cancer Research Center | 2012-04-01 |
| A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone (NCT01544179) | AstraZeneca | 2012-03-15 |
| An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) (NCT01598597) | Genentech, Inc. | 2012-03-01 |
| Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients (NCT01588145) | Hanmi Pharmaceutical Company Limited | 2012-03-01 |
| Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer (NCT01565772) | Massachusetts General Hospital | 2012-03-01 |
| Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers (NCT01502202) | National Cancer Center, Korea | 2012-03-01 |
| GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial (NCT02319577) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2012-03-01 |
| Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer (NCT01593293) | Asan Medical Center | 2012-03-01 |
| Integrated Molecular Profiling in Advanced Cancers Trial (NCT01505400) | University Health Network, Toronto | 2012-02-01 |
| A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT01560104) | AbbVie (prior sponsor, Abbott) | 2012-02-01 |
| A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT01667562) | Hoffmann-La Roche | 2012-01-20 |
| Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer (NCT01493843) | Genentech, Inc. | 2012-01-20 |
| Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC) (NCT01951755) | University of Athens | 2012-01-01 |
| Genotyping of Non-small Cell Lung Cancer (NCT02002117) | National Taiwan University Hospital | 2012-01-01 |
| A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors (NCT01457417) | Leap Therapeutics, Inc. | 2012-01-01 |
| Common Safety Follow-up Trial of Tecemotide (L-BLP25) (NCT01423760) | Merck KGaA, Darmstadt, Germany | 2012-01-01 |
| Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC) (NCT01837186) | University Hospital, Gasthuisberg | 2012-01-01 |
| Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC (NCT01963351) | University of Athens | 2012-01-01 |
| Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients (NCT01402089) | Markus Joerger | 2012-01-01 |
| Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment (NCT01520389) | Merrimack Pharmaceuticals | 2012-01-01 |
| Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment (NCT02895503) | Virginia Commonwealth University | 2012-01-01 |
| Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer (NCT01542437) | Instituto Nacional de Cancerologia de Mexico | 2012-01-01 |
| RT Plus EGFR-TKI for Wild-type NSCLC (NCT02738983) | Hangzhou Cancer Hospital | 2012-01-01 |
| Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II (NCT01649947) | Rutgers, The State University of New Jersey | 2011-12-23 |
| Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) (NCT01454102) | Bristol-Myers Squibb | 2011-12-16 |
| Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer (NCT01407822) | Guangdong Association of Clinical Trials | 2011-12-05 |
| Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung (NCT01561456) | Axelar AB | 2011-12-01 |
| Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation (NCT01516983) | Betta Pharmaceuticals Co., Ltd. | 2011-12-01 |
| ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC (NCT01810367) | Fudan University | 2011-12-01 |
| Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC (NCT01528488) | Sun Yat-sen University | 2011-12-01 |
| Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer (NCT01504542) | Heat Biologics | 2011-12-01 |
| Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging (NCT01473693) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments (NCT01529112) | Eisai Inc. | 2011-11-01 |
| Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy (NCT01482182) | Samsung Medical Center | 2011-11-01 |
| Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer (NCT01532362) | Jonsson Comprehensive Cancer Center | 2011-11-01 |
| Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients (NCT01441752) | xuling | 2011-11-01 |
| Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease (NCT01450553) | Precision Therapeutics | 2011-10-01 |
| A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers (NCT01451632) | Merrimack Pharmaceuticals | 2011-10-01 |
| A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy (NCT01351116) | Ontario Clinical Oncology Group (OCOG) | 2011-10-01 |
| A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations (NCT01287754) | Hoffmann-La Roche | 2011-10-01 |
| Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation (NCT01405079) | Guangdong Association of Clinical Trials | 2011-09-19 |
| Study of Use of CTC in NSCLC (NCT01990651) | University of Virginia | 2011-09-01 |
| A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients (NCT01531790) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2011-09-01 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer (NCT01950156) | Shiga University | 2011-09-01 |
| Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose (NCT01465243) | Betta Pharmaceuticals Co., Ltd. | 2011-09-01 |
| Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer (NCT01525446) | Massachusetts General Hospital | 2011-09-01 |
| A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers (NCT01521325) | Morphotek | 2011-09-01 |
| Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy (NCT01664663) | Ass. Prof. Jan Nyman | 2011-09-01 |
| Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone (NCT01513174) | Spanish Lung Cancer Group | 2011-08-01 |
| Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer (NCT01949701) | Shiga University | 2011-08-01 |
| Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) (NCT01549093) | Hunan Province Tumor Hospital | 2011-08-01 |
| CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) (NCT01533727) | Sun Yat-sen University | 2011-08-01 |
| Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) (NCT01387269) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib (NCT02747953) | Samsung Medical Center | 2011-07-01 |
| Safety Study of MGA271 in Refractory Cancer (NCT01391143) | MacroGenics | 2011-07-01 |
| Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT01355484) | GTx | 2011-07-01 |
| Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum (NCT01355497) | GTx | 2011-07-01 |
| Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression (NCT01401192) | Samsung Medical Center | 2011-07-01 |
| Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) (NCT01395914) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |